Manufacturing NK cells for the clinic: the Spanish experience
Cell & Gene Therapy Insights 2022; 8(8), 1539–1549
DOI: 10.18609/cgti.2022.225
Published: 14 December 2022
Innovator Insight
This article will discuss a standardized method for manufacturing a high number of clinical-grade NK cells ideal for infusion into patients, expand on the optimization of protocols, and provide a glimpse into the clinical results of infused NK cells at a hospital in Madrid, Spain.